Apnea in the Current Era: Diagnostics, Therapeutics, Adherence is organized by eMedEvents. Description: This webinar will discuss how to help OSA patients remain compliant with their therapy during this time of transition. What should be taken into account: most recent PAP interface technologies, PAP adherence strategies, and should we consider alternative and multimodality therapies? For our patients to remain compliant with their sleep therapy, we may need to change and or combine treatments. Educational Objectives: Addressing the knowledge gap for the changes occurring in diagnosing and treating sleep-disordered breathing in the time of Covid-19. Review of the adherence strategies and technological advances available for addressing compliance issues with PAP therapy. Introducing the concept of multimodality and alternative therapeutics in the treatment of sleep-disordered breathing. Continuing Education for Physicians:   This educational activity is approved for 1 CME contact hour for physicians. The link to obtain CME credits will be provided at the conclusion of the webinar. Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and eMedEvents. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.SynAptiv designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  Continuing Education for Nurses and Respiratory Therapists:   This educational activity is approved for 1 contact hour for Nurses and RTs. The link to obtain CE credits will be provided at the conclusion of the webinar. Accreditation Statement: Synaptiv is accredited as a provider for continuing education. Provider approved by California Board of Nursing. Provider #14477  and the Florida Board of Nursing Provider # 50-17032. This program has been approved for 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063.  

Oxygen Therapy: What you need to know to get it right for your patients. This webinar discusses evaluation and testing requirements for Long Term Oxygen Therapy (LTOT) treatment, documentation guidelines for writing the proper prescription, considerations regarding matching the right oxygen delivery system to the clinical and lifestyle needs of the patient, as well as, identifying the gaps that contribute to poor adherence to long term oxygen therapy and recommendations for possible solutions. Educational Objectives: List the methods for evaluating the need for Long Term Oxygen Therapy (LTOT), and qualifying a patient for home oxygen coverage.  How to write a proper oxygen prescription. Match the oxygen delivery system to meet the clinical and lifestyle needs of the patient. Identify the gaps that contribute to poor adherence to long term oxygen therapy and list possible solutions. Continuing Education for Physicians:  This educational activity is approved for 1 contact hour for Physicians. The link to obtain CME credits will be provided at the conclusion of the webinar. Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of SynAptivand eMedEvents. SynAptivis accredited by the ACCME to provide 1 AMA PRA Category 1 Credit™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Education for Nurses and Respiratory Therapists: This educational activity is approved for 1 contact hour for Nurses and RRTs. The link to obtain CE credits will be provided at the conclusion of the webinar. Accreditation Statement: Synaptivis accredited as a provider for continuing education. Provider approved by California Board of Nursing. Provider #14477and the Florida Board of Nursing Provider # 50-17032.This program has been approved for 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063.      

Institute of Emerging Health Professions - Cannabinoid Pharmacology is organized by Thomas Jefferson University (TJU).  The graduate certificate in Cannabinoid Pharmacology is outlined to prepare learners with the mechanisms of drug action and highlights of pharmacokinetics as it correlates to cannabis. Continue Education Credits: Applied CNS Pharmacology and Toxicology (optional)--- 3 Hours Cannabinoid Pharmacology & Toxicology --- 3 Hours Cannabinoid Pharmacokinetics --- 3 Hours Cultural History, Regulation, and Policy of Cannabis --- 3 Hours OR Cannabinoid Research Design --- 3 Hours Overview: The legal cannabis industry is expected to be one of the fastest-growing sectors of the US economy over the next decade. There are, however, some educational assemblies that present scientists, researchers, and clinicians to join this burgeoning field. This is the very first-of-its-kind graduate certificate in Cannabinoid Pharmacology, which is now accessible for interested students with a proper background in chemistry, biochemistry, pharmacology, toxicology, or physiology. Objectives: At the conclusion of the online CME Certification in Cannabinoid Pharmacology program, students must be able to, • Access drug action mechanisms(pharmacodynamics) • Define central nervous system neurotransmission • Explain features of pharmacokinetics (administration, distribution, metabolism, excretion) • Describe the pharmacology of stimulants, depressants, cannabinoids, hallucinogens, antipsychotics • Illustrate the prevailing awareness of drug abuse complications and addiction • Explain the historical use of cannabis • Examine the changes in public opinion about cannabis use • Learn past and prevailing US government cannabis-related regulations and regulatory topics Fall 2020 Start Date:  September 1, 2020 Program Length: 1-2 years FALL 2018: • Applied CNS Pharmacology and Toxicology (prerequisite) Course Number: CPY 500 Credit Hours: 3 • Cultural History, Regulation, and Policy of Cannabis Course Number: CPY 510 Credit Hours: 3 SPRING 2019: • Cannabinoid Pharmacology & Toxicology Course Number: CPY 501 Credit Hours: 3 SUMMER 2019: • Cannabinoid Pharmacokinetics Course Number: CPY 506 Credit Hours: 3

Sleep Medicine in 2020 and Moving Forward is organized by eMedEvents. Description: This webinar will discuss the changes in sleep medicine during the COVID-19 pandemic. In the future, what should be considered when testing, diagnosing, and treating our sleep patients? What new methods and therapies are being prescribed? Will these changes stay beyond 2020? Educational Objectives: Review some changes in the clinical practice of sleep medicine that have occurred due to COVID-19. Discuss alternate patient care models. Examine some strategies to mitigate COVID-19 risks. Explore the abundance of opportunities available to improve the sleep health of our communities. Continuing Education for Physicians: This educational activity is approved for 1 contact hour for Physicians. The link to obtain CME credits will be provided at the conclusion of the webinar. Accreditation Statement:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and eMedEvents. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians. SynAptiv designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  Continuing Education for Nurses and Respiratory Therapists:   This educational activity is approved for 1 contact hour for Nurses and RTs. The link to obtain CE credits will be provided at the conclusion of the webinar. Accreditation Statement: Synaptiv is accredited as a provider for continuing education. Provider approved by California Board of Nursing. Provider #14477  and the Florida Board of Nursing Provider # 50-17032. This program has been approved for 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving, TX 75063.  

The Institute of Emerging Health Professions - Cannabis Medicine is organized by Thomas Jefferson University (TJU). The symposium is held from  Sep 04, 2018 - Sep 04, 2020. The Certificate in Cannabis Medicine is intended to equip clinicians with the knowldege of  latest cannabinoid therapies and their health effects. FALL 2018: • Cultural History, Regulation, and Policy of Cannabis (optional) This session is not Required but Can be taken Instead of Cannabinoid Research Design Course Number: CPY 510 Credit Hours: 3 SPRING 2019: • Pathology of Diseases and Current Therapeutic Options (prerequisite) Course Number: CMD 503 Credit Hours: 3 • Cannabinoid Research Design Course Number: CMD 520 Credit Hours: 3 SUMMER 2019: • Evidence based Cannabinoid Pharmacotherapy Course Number: CMD 504 Credit Hours: 3 FALL 2019: • Negative Health Effects of Cannabis and Cannabinoids Course Number: CMD 505 Credit Hours: 3 • Pathology of Diseases and Current Therapeutic Options (prerequisite) Course Number: CMD 503 Credit Hours: 3 Additional details will be posted as soon as they are available.

The Newly Hired Radiologist: Lessons for Aspiring, New, and Experienced Radiologists is organized by Radiological Society of North America (RSNA) and will be held during Mar 16, 2018 - Mar 15, 2021. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credit(s). Conference Objectives are : • Describe the needs and challenges faced by the radiology department and the new hire, with respect to a beginning radiologist. This includes providing guidance on how to find an expertise 'niche,' and how to divide time between clinical work, committee volunteerism, and leadership roles. • Discuss the impact of social media and patient portals on the physician-patient interaction and identify the risks and benefits of these new opportunities for communication. • Identify the issues facing a private practice group when incorporating a new partner including questions of fairness/transparency, patience with colleagues, formal and informal mentorship, and communicating expectations. • Discuss the ways in which a radiology group can assist a new radiologist transitioning out of training, in order to bring out the best in their new colleague and help them to live up to and exceed their highest potential. Additional details will be posted as soon as they are available.

Neurology: Focal myositis: New insights on diagnosis and pathology is organized by American Academy of Neurology (AAN) and will be held from Mar 20, 2018 - Mar 20, 2021. The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits. Conference Objectives are : • Upon completion of the article by Gallay et al, the participant should be able to: • Discuss the symptoms most frequently reported by patients with focal myositis (FM) in this study • Discuss which laboratory results were most frequently abnormal in patients with FM in this study • State the approximate relapse rate of FM in this study Additional details will be posted as soon as they are available.

Neurology: Attention-deficit/hyperactivity disorder medication and seizures is organized by American Academy of Neurology (AAN) and will be held from Mar 27, 2018 - Mar 27, 2021. The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits. Learning Objectives: Upon completion of the article by Wiggs et al, the participant should be able to: • Describe the relationship between attention-deficit/hyperactivity disorder (ADHD) diagnosis and risk of experiencing at least one seizure observed in this study • Discuss the association between ADHD medication use and seizure risk in patients with and without prior history of seizure seen in this study • Discuss the association between long-term (≥ 2 years) use of ADHD medications and risk of seizure seen in this study Additional details will be posted as soon as they are available.

Neurology: Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation is organized by American Academy of Neurology (AAN) and will be held from Mar 27, 2018 - Mar 27, 2021. The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits. Learning Objectives: Upon completion of the article by Ekblad et al, the participant should be able to: • Describe the association between the presence of insulin resistance (IR) and the likelihood of having an amyloid- positive PET scan in this study • Discuss the relationship between IR, the presence of APOE ε4 allele(s), and the likelihood of amyloid-positive PET scan results in this study • Describe the relationship between timing of IR (midlife versus late-life) and the likelihood of amyloid-positive PET scan results in this study Additional details will be posted as soon as they are available.

Neurology: Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy is organized by American Academy of Neurology (AAN) and will be held from Apr 03, 2018 - Apr 03, 2021. The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits Learning Objectives: Upon completion of the article by Karaa et al, the participant should be able to: • Briefly discuss potential therapeutic mechanisms of elamipretide described in this study • Discuss significant improvement in outcomes at day 5 in patients receiving the highest dose of elamipretide compared to those receiving placebo in this study • State the most common adverse effect in the treatment group and how this compared to the placebo group Additional details will be posted as soon as they are available.